Malignant pleural and pericardial effusions and meningeal infiltrates without other metastases in breast cancer: A case report

Lv,Xingxing; He,Jinlan; Shen,Yuan; Zheng,Hong

doi:10.3892/mco.2016.798

Malignant pleural and pericardial effusions and meningeal infiltrates without other metastases in breast cancer: A case report

Authors:
- Xingxing Lv
- Jinlan He
- Yuan Shen
- Hong Zheng
View Affiliations

Affiliations: Department of Head & Neck and Mammary Oncology and Medical Oncology, Cancer Center and State Key Laboratory of Biotherapy, Laboratory of Molecular Diagnosis of Cancer, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, P.R. China, Department of General Practice, West China School of Clinical Medicine, Sichuan University, Chengdu, Sichuan 610041, P.R. China
Published online on: March 2, 2016 https://doi.org/10.3892/mco.2016.798
Pages: 855-858

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer metastasizing to the pleura, pericardium and leptomeninges, but not to other sites, is rare. although malignant pericardial and pleural effusions are common complications during the course of malignancies, they are rarely the initial manifestations of malignant disease, particularly pericardial effusion with cardiac tamponade. This report describes a case of breast carcinoma in a 44‑year‑old woman who initially presented with malignant pleural effusion and pericardial tamponade and suffered from meningeal metastases after 4.5 months. Unfortunately, the patient succumbed to pericardial tamponade 7 months later. There was no metastasis identified in other organs during the course of the disease. To the best of our knowledge, no similar case has been reported in the literature to date.

View Figures

View References

1	Koo JS, Jung W and Jeong J: Metastatic breast cancer shows different immunohistochemical phenotype according to metastatic site. Tumori. 96:424–432. 2010.PubMed/NCBI
2	Apffelstaedt JP, Van Zyl JA and Muller AG: Breast cancer complicated by pleural effusion: Patient characteristics and results of surgical management. J Surg Oncol. 58:173–175. 1995. View Article : Google Scholar : PubMed/NCBI
3	Evans TRJ, Stein RC, Pepper JR, Gazet JC, Ford HT and Coombes RC: A randomized prospective trial of surgical against medical tetracycline pleurodesis in the management of malignant pleural effusions secondary to breast-cancer. Eur J Cancer. 29A:316–319. 1993. View Article : Google Scholar : PubMed/NCBI
4	Posner MR, Cohen GI and Skarin AT: Pericardial disease in patients with cancer. The differentiation of malignant from idiopathic and radiation-induced pericarditis. Am J Med. 71:407–413. 1981. View Article : Google Scholar : PubMed/NCBI
5	Levitan Z, Kaplan AL and Gordon AN: Survival after malignant pericardial effusion and cardiac tamponade in advanced ovarian cancer. South Med J. 83:241–242. 1990. View Article : Google Scholar : PubMed/NCBI
6	Shetty J, Prasad K, Rao M and Nayak A: Isolated leptomeningeal metastases originating from infiltrating ductal carcinoma of breast - A case report. IJRRMS. 2:2012.
7	Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T and Thun MJ: Cancer statistics, 2008. CA Cancer J Clin. 58:71–96. 2008. View Article : Google Scholar : PubMed/NCBI
8	Largillier R, Ferrero JM, Doyen J, Barriere J, Namer M, Mari V, Courdi A, Hannoun-Levi JM, Ettore F and Birtwisle-Peyrottes I: Prognostic factors in 1,038 women with metastatic breast cancer. Ann Oncol. 19:2012–2019. 2008. View Article : Google Scholar : PubMed/NCBI
9	Bruna J, Simó M and Velasco R: Leptomeningeal metastases. Curr Treat Options Neurol. 14:402–415. 2012. View Article : Google Scholar : PubMed/NCBI
10	Ugenskiené R and Juozaityté E: The molecular mechanisms of breast cancer metastasis. Biologija. 58:2012.
11	Hortobagyi GN: Can we cure limited metastatic breast cancer? J Clin Oncol. 20:620–623. 2002.PubMed/NCBI
12	Greenberg PA, Hortobagyi GN, Smith TL, Ziegler LD, Frye DK and Buzdar AU: Long-term follow-up of patients with complete remission following combination chemotherapy for metastatic breast cancer. J Clin Oncol. 14:2197–2205. 1996.PubMed/NCBI
13	Dawood S, Broglio K, Ensor J, Hortobagyi GN and Giordano SH: Survival differences among women with de novo stage IV and relapsed breast cancer. Ann Oncol. 21:2169–2174. 2010. View Article : Google Scholar : PubMed/NCBI
14	Güth U, Magaton I, Huang DJ, Fisher R, Schötzau A and Vetter M: Primary and secondary distant metastatic breast cancer: Two sides of the same coin. Breast. 23:26–32. 2014. View Article : Google Scholar : PubMed/NCBI
15	Weigelt B, Peterse JL and van't Veer LJ: Breast cancer metastasis: Markers and models. Nat Rev Cancer. 5:591–602. 2005. View Article : Google Scholar : PubMed/NCBI
16	Solomayer EF, Diel IJ, Meyberg GC, Gollan C and Bastert G: Metastatic breast cancer: Clinical course, prognosis and therapy related to the first site of metastasis. Breast Cancer Res Treat. 59:271–278. 2000. View Article : Google Scholar : PubMed/NCBI
17	Cutler SJ, Ardyce JA and Taylor SG III: Classification of patients with disseminated cancer of the breast. Cancer. 24:861–869. 1969. View Article : Google Scholar : PubMed/NCBI
18	Fentiman IS, Millis R, Sexton S and Hayward JL: Pleural effusion in breast cancer: A review of 105 cases. Cancer. 47:2087–2092. 1981. View Article : Google Scholar : PubMed/NCBI
19	Dieterich M, Goodman SN, Rojas-Corona RR, Emralino AB, Jimenez-Joseph D and Sherman ME: Multivariate analysis of prognostic features in malignant pleural effusions from breast cancer patients. Acta Cytol. 38:945–952. 1994.PubMed/NCBI
20	Hirata T, Yonemori K, Hirakawa A, Shimizu C, Tamura K, Ando M, Katsumata N, Tanimoto M and Fujiwara Y: Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients. Eur Respir J. 38:1425–1430. 2011. View Article : Google Scholar : PubMed/NCBI
21	Stitt VJ Jr: Breast carcinoma with pericardial metastasis. J Natl Med Assoc. 79:195–197. 1987.PubMed/NCBI
22	Scott BJ and Kesari S: Leptomeningeal metastases in breast cancer. Am J Cancer Res. 3:117–126. 2013.PubMed/NCBI
23	Rodríguez-Pinilla SM, Sarrió D, Honrado E, Hardisson D, Calero F, Benitez J and Palacios J: Prognostic significance of basal-like phenotype and fascin expression in node-negative invasive breast carcinomas. Clin Cancer Res. 12:1533–1539. 2006. View Article : Google Scholar : PubMed/NCBI
24	Chang BW, Decker RH, Haffty BG and Knisely JPS: Incidence of brain metastases in early-stage triple negative breast cancer patients. Int J Radiat Oncol Biol Phys. 69(Suppl): S210–S211. 2007. View Article : Google Scholar
25	Lin Y, Yin W, Yan T, Zhou L, Di G, Wu J, Shen Z, Shao Z and Lu J: Site-specific relapse pattern of the triple negative tumors in Chinese breast cancer patients. BMC Cancer. 9:3422009. View Article : Google Scholar : PubMed/NCBI
26	Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB and Kim WK: Brain metastases in breast cancer: Prognostic factors and management. Breast Cancer Res Treat. 111:523–530. 2008. View Article : Google Scholar : PubMed/NCBI
27	Santos GT, Prolla JC, Camillo ND, Zavalhia LS, Ranzi AD and Bica CG: Clinical and pathological factors influencing the survival of breast cancer patients with malignant pleural effusion. J Bras Pneumol. 38:487–493. 2012. View Article : Google Scholar : PubMed/NCBI
28	Chang EL and Lo S: Diagnosis and management of central nervous system metastases from breast cancer. Oncologist. 8:398–410. 2003. View Article : Google Scholar : PubMed/NCBI